Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,987 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As lawmakers push hundreds of AI bills, a lack of universal testing leaves companies and investors facing a maze of r...
A new Seattle class-action accuses Amazon of retaining hundreds of millions in tariff revenue by raising consumer pri...
A message that seems to come from the boss can trigger a chain of costly actions. This guide breaks down how these sc...
Micron has surged into a market-defining position as traders weigh earnings potential against memory-price risk. Anal...
NuScale Power stock surged to a record before succumbing to a mix of policy, funding, and project risks. This guide b...
Amazon Web Services released a landmark study on AI agent drift, arguing that the link between models and tools needs...
A sudden antivirus alert can look legitimate—until you realize it's a scam. This article breaks down how these tricks...
A downtown Pittsburgh convenience store is at the center of allegations that SNAP benefits were converted to cash and...
As digital money builds pace, the Bank of England signals a nuanced approach to stablecoins. This piece explains what...
Crypto fans are buzzing about pump.fun's latest experiment already changing how tasks get done in the digital world. ...
The passing of kenyan tiktoker malon kiptarus at Dubai’s Jumeirah Beach shines a light on money matters for expats. T...